| For: | Zhou J, Chooi JY, Ching YQ, Quah JY, Toh SHM, Ng Y, Tan TZ, Chng WJ. NF-κB promotes the stem-like properties of leukemia cells by activation of LIN28B. World J Stem Cells 2018; 10(4): 34-42 [PMID: 29707103 DOI: 10.4252/wjsc.v10.i4.34] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v10/i4/34.htm |
| Number | Citing Articles |
| 1 |
Barbara Di Francesco, Daniela Verzella, Daria Capece, Davide Vecchiotti, Mauro Di Vito Nolfi, Irene Flati, Jessica Cornice, Monica Di Padova, Adriano Angelucci, Edoardo Alesse, Francesca Zazzeroni. NF-κB: A Druggable Target in Acute Myeloid Leukemia. Cancers 2022; 14(14) doi: 10.3390/cancers14143557
|
| 2 |
Chune Ren, Xue Han, Chao Lu, Tingting Yang, Pengyun Qiao, Yonghong Sun, Zhenhai Yu. Ubiquitination of NF-κB p65 by FBXW2 suppresses breast cancer stemness, tumorigenesis, and paclitaxel resistance. Cell Death & Differentiation 2022; 29(2) doi: 10.1038/s41418-021-00862-4
|
| 3 |
Faten Merhi, Daniel Dauzonne, Brigitte Bauvois. Implementation of Natural Products and Derivatives in Acute Myeloid Leukemia Management: Current Treatments, Clinical Trials and Future Directions. Cancers 2026; 18(2) doi: 10.3390/cancers18020185
|
| 4 |
Ewa Kowalewska, Joanna Kamińska, Marta Żebrowska-Nawrocka, Ewa Balcerczak, Magdalena Rybaczek, Tomasz Łysoń, Marzena Tylicka, Natalia Wawrusiewicz-Kurylonek, Joanna Matowicka-Karna, Olga Martyna Koper-Lenkiewicz. Expression of NF-κB Isoforms and IKK Complex Subunits Differs in Peripheral Blood Mononuclear Cells (PBMCs) of Patients with Meningiomas: A Pilot Study. Life 2026; 16(6) doi: 10.3390/life16060880
|
| 5 |
Ana Carolina B. da C. Rodrigues, Rafaela G.A. Costa, Suellen L.R. Silva, Ingrid R.S.B. Dias, Rosane B. Dias, Daniel P. Bezerra. Cell signaling pathways as molecular targets to eliminate AML stem cells. Critical Reviews in Oncology/Hematology 2021; 160 doi: 10.1016/j.critrevonc.2021.103277
|
| 6 |
Salihanur Darici, Hazem Alkhaldi, Gillian Horne, Heather G. Jørgensen, Sandra Marmiroli, Xu Huang. Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence. Journal of Clinical Medicine 2020; 9(9) doi: 10.3390/jcm9092934
|
| 7 |
Sumon Mukherjee, Subhadip Pati, Subhanki Dhar, Tania Sarkar, Silpita Paul, Udit Basak, Sourio Chakraborty, Gaurisankar Sa. The Role of Nuclear Factor-κB in Cancer Immunity and Immunoediting. Cancer Control 2025; 32 doi: 10.1177/10732748251406677
|
| 8 |
Mahdi Pakjoo, Seyed Esmaeil Ahmadi, Mohammad Zahedi, Niloofar Jaafari, Reyhane Khademi, Ali Amini, Majid Safa. Interplay between proteasome inhibitors and NF-κB pathway in leukemia and lymphoma: a comprehensive review on challenges ahead of proteasome inhibitors. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-023-01433-5
|
| 9 |
Assia Drif, Rümeysa Yücer, Roxana Damiescu, Nadeen Ali, Tobias Abu Hagar, Bharati Avula, Ikhlas Khan, Thomas Efferth. Anti-Inflammatory and Cancer-Preventive Potential of Chamomile (Matricaria chamomilla L.): A Comprehensive In Silico and In Vitro Study. Biomedicines 2024; 12(7) doi: 10.3390/biomedicines12071484
|
| 10 |
Caifang Zhao, Xiang Weng, Wei He. Identification of cell adhesion related signature for molecular subtyping and prognostic prediction in acute myeloid leukemia. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-03208-5
|
| 11 |
Jianbiao Zhou, Wee-Joo Chng. Resistance to FLT3 inhibitors in acute myeloid leukemia: Molecular mechanisms and resensitizing strategies. World Journal of Clinical Oncology 2018; 9(5): 90-97 doi: 10.5306/wjco.v9.i5.90
|
| 12 |
Minran Zhou, Xiaolin Yin, Lu Zhang, Zelong Cui, Xinwen Jiang, Qingli Ji, Sai Ma, Chunyan Chen. RNA-Binding Protein Lin28B Promotes Chronic Myeloid Leukemia Blast Crisis by Transcriptionally Upregulating miR-181d. Molecular Cancer Research 2024; 22(10) doi: 10.1158/1541-7786.MCR-23-0928
|
| 13 |
Yunlu Jia, Wee-Joo Chng, Jianbiao Zhou. Super-enhancers: critical roles and therapeutic targets in hematologic malignancies. Journal of Hematology & Oncology 2019; 12(1) doi: 10.1186/s13045-019-0757-y
|